Trident Lifeline Ltd

Trident Lifeline Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Trident Lifeline Ltd

₹ 266 -2.39%
15 Jan 4:01 p.m.
tridentlifeline.com BSE - SME: 543616
About

Incorporated in 2014, Trident Lifeline Ltd manufactures and sells pharmaceuticals
products[1]

Key Points

Business Overview:[1]
TFL is a pharmaceutical Company with business operations spanning formulations under its own brands, loan licence model and contract manufacturing model.
a) Pharmaceutical formulations export:
Company has a presence in 40 countries, including African, Latin America, and East
Asian countries, with ~945 registered export market products, and ~2016 export market products are under registration
b) Contract manufacturing:
Company follows an Asset-light third-party contract manufacturing model thus entailing limited direct investment in manufacturing capacities

Website BSE
  • Market Cap ₹ 306 Cr.
  • Current Price ₹ 266
  • High / Low ₹ 339 / 136
  • Stock P/E 29.6
  • Book Value ₹ 51.4
  • Dividend Yield 0.00 %
  • ROCE 19.1 %
  • ROE 14.3 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Mar 2024 Jun 2024 Sep 2024
4.46 8.95 5.97 7.85 9.41 8.46 8.64 9.93 18.99 14.74 15.66
5.04 7.19 5.11 6.26 7.42 6.51 6.88 7.73 16.03 10.66 11.24
Operating Profit -0.58 1.76 0.86 1.59 1.99 1.95 1.76 2.20 2.96 4.08 4.42
OPM % -13.00% 19.66% 14.41% 20.25% 21.15% 23.05% 20.37% 22.16% 15.59% 27.68% 28.22%
0.03 0.17 0.01 0.12 0.39 0.63 0.33 0.38 1.26 0.47 0.52
Interest 0.03 0.07 0.08 0.17 0.13 0.15 0.10 0.11 0.14 0.20 0.27
Depreciation 0.05 0.05 0.09 0.06 0.13 0.12 0.13 0.16 0.19 0.33 0.16
Profit before tax -0.63 1.81 0.70 1.48 2.12 2.31 1.86 2.31 3.89 4.02 4.51
Tax % 0.00% -53.04% 0.00% 0.00% 4.72% 14.29% 24.73% 25.97% 37.02% 25.12% 24.83%
-0.63 2.77 0.70 1.48 2.02 1.97 1.40 1.71 2.45 3.01 3.39
EPS in Rs -0.97 3.46 0.88 1.85 1.76 1.71 1.22 1.49 2.13 2.62 2.95
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
4.93 9.62 21.77 31.69 44.65
5.20 8.37 19.05 25.42 35.77
Operating Profit -0.27 1.25 2.72 6.27 8.88
OPM % -5.48% 12.99% 12.49% 19.79% 19.89%
0.07 0.16 0.60 1.15 2.20
Interest 0.76 0.41 0.13 0.48 0.51
Depreciation 0.12 0.14 0.20 0.36 0.77
Profit before tax -1.08 0.86 2.99 6.58 9.80
Tax % -25.93% 25.58% -32.11% 8.51% 28.06%
-0.80 0.63 3.95 6.01 7.04
EPS in Rs -2.58 1.26 4.94 5.23 6.12
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 67%
TTM: 55%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 123%
TTM: 46%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 33%
Return on Equity
10 Years: %
5 Years: %
3 Years: 22%
Last Year: 14%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 3.10 5.00 8.00 11.50 11.50 11.50
Reserves -6.10 -5.47 -3.22 34.13 41.18 47.58
6.46 4.53 2.46 3.38 6.20 8.79
2.93 7.39 6.59 7.49 14.36 16.05
Total Liabilities 6.39 11.45 13.83 56.50 73.24 83.92
0.77 1.18 1.43 3.11 7.62 13.19
CWIP 0.00 0.00 0.00 0.23 4.03 1.16
Investments 0.00 0.00 0.05 4.04 4.40 4.73
5.62 10.27 12.35 49.12 57.19 64.84
Total Assets 6.39 11.45 13.83 56.50 73.24 83.92

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
-0.59 1.48 -0.19 -16.60 0.90
-0.08 -0.56 -0.50 -5.56 -11.01
0.76 -0.96 0.80 35.80 2.35
Net Cash Flow 0.08 -0.03 0.11 13.64 -7.76

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 96.99 24.28 83.33 139.94 112.48
Inventory Days 103.66 349.10 95.16 129.36 136.57
Days Payable 201.80 266.30 134.15 86.78 93.60
Cash Conversion Cycle -1.15 107.09 44.34 182.52 155.45
Working Capital Days -11.85 11.76 66.73 307.18 267.07
ROCE % 33.78% 55.22% 25.10% 19.07%

Shareholding Pattern

Numbers in percentages

Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
69.85% 69.99% 70.04% 70.04% 70.04% 67.48% 65.50% 62.99% 62.99%
4.20% 4.39% 4.36% 4.64% 4.64% 6.02% 6.02% 6.09% 6.09%
25.95% 25.61% 25.58% 25.31% 25.31% 26.49% 28.47% 30.93% 30.92%
No. of Shareholders 397388387439481500502507523

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls

  • Oct 2024
    Transcript
    Notes
    PPT
  • Jul 2024
    Transcript
    Notes
    PPT
  • May 2024
    Transcript
    Notes
    PPT
  • Nov 2023
    Transcript
    Notes
    PPT
  • Jul 2023
    Transcript
    Notes
    PPT
  • May 2023
    Transcript
    Notes
    PPT
  • Jan 2023
    Transcript
    Notes
    PPT